We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Alemtuzumab (rch)
Australian Public Assessment Report
Device/Product Name
Lemtrada / Remniq
Active ingredients
Alemtuzumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2012-02297-3-1
Submission Type
New dosage strength, New patient group, New dosage regime
Decision
Approved